Mefloquine warnings and precautions: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Mefloquine}} {{CMG}}; {{AE}} {{chetan}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MEFLOQUINE HYDROCHLORIDE TABLET [BARR LABORA..." |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Mefloquine}} | {{Mefloquine}} | ||
{{CMG}}; {{AE}} {{chetan}} | {{CMG}}; {{AE}} {{chetan}} | ||
{| | |||
|- | |||
| [[File:MEFLOQUINE1.jpg|800px|thumb]] | |||
|- | |||
|} | |||
Revision as of 01:00, 8 January 2014
| Mefloquine |
|---|
| MEFLOQUINE HYDROCHLORIDE® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Microbiology |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Overdosage |
| Dosage and Administration |
| How Supplied |
| Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
 |
References
Adapted from the FDA Package Insert.